Antiepileptic drugs not tied to dementia risk

Antiepileptic drugs not tied to dementia risk

(HealthDay)—Antiepileptic drug (AED) use is not significantly associated with dementia risk in patients in Germany, according to a study published online March 12 in the Journal of Alzheimer's Disease.

Louis Jacob, Ph.D., from the University of Versailles Saint-Quentin-en-Yvelines in France, and colleagues examined the association between AED use and dementia risk among 50,575 cases with dementia and 50,575 controls without dementia in Germany. Cases and controls were matched by age, gender, physician, diagnosis of mild cognitive impairment, and observation time prior to the index date.

The researchers found no significant association between AED use and dementia risk in either model 1, comparing ever versus never use, or model 2, assessing duration of treatment (in years). An increased was seen for prescriptions of levetiracetam generic brands (model 1: odds ratio, 1.7; model 2: odds ratio, 1.36).

"It is possible that some of the newest generic brands of levetiracetam may have on cognitive function in older individuals with epilepsy and that these effects have not been investigated yet," the authors write.

Explore further

No association between antiepileptic drug use and dementia

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Journal of Alzheimer's Disease

Copyright © 2019 HealthDay. All rights reserved.

Citation: Antiepileptic drugs not tied to dementia risk (2019, March 21) retrieved 26 January 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments